Towards reproducible MRM based biomarker discovery using dried blood spots

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Ozcan, Sureyya ^a   Cooper, Jason D ^a   Lago, Santiago G ^a   Kenny, Diarmuid ^b   Rustogi, Nitin ^a   Stocki, Pawel ^b   Bahn, Sabine ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b Psynova Neurotech Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PEPTIDE;

BLOOD; DRIED BLOOD SPOT TESTING; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MALE; PERSONALIZED MEDICINE; PROCEDURES; PROTEOMICS; REPRODUCIBILITY; TANDEM MASS SPECTROMETRY;

BIOMARKERS; CHROMATOGRAPHY, LIQUID; DRIED BLOOD SPOT TESTING; FEMALE; HUMANS; MALE; PEPTIDES; PRECISION MEDICINE; PROTEOMICS; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY;

EID: 85016231345     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep45178     Document Type: Article

References (41)

1. Hoofnagle, A. N. & Wener, M. H. The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry. Journal of immunological methods 347, 3-11, doi: 10.1016/j.jim.2009.06.003 (2009).
2. Chan, M. K., Cooper, J. D. & Bahn, S.commercialisation of Biomarker Tests for Mental Illnesses: Advances and Obstacles. Trends in biotechnology 33, 712-723, doi: 10.1016/j.tibtech.2015.09.010 (2015).
3. Ebhardt, H. A., Root, A., Sander, C. & Aebersold, R. Applications of targeted proteomics in systems biology and translational medicine. Proteomics 15, 3193-3208, doi: 10.1002/pmic.201500004 (2015).
4. Domon, B. & Aebersold, R. Options and considerations when selecting a quantitative proteomics strategy. Nat Biotechnol 28, 710-721, doi: 10.1038/nbt.1661 (2010).
5. Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteomewide protein quantification. Nat Biotechnol 26, 1367-1372, doi: 10.1038/nbt.1511 (2008).
6. Lange, V., Picotti, P., Domon, B. & Aebersold, R. Selected reaction monitoring for quantitative proteomics: a tutorial. Mol Syst Biol 4, 222, doi: 10.1038/msb.2008.61 (2008).
7. Surinova, S. et al. Automated selected reaction monitoring data analysis workflow for large-scale targeted proteomic studies. Nat Protoc 8, 1602-1619, doi: 10.1038/nprot.2013.091 (2013).
8. Chambers, A. G., Percy, A. J., Hardie, D. B. & Borchers, C. H.comparison of proteins in whole blood and dried blood spot samples by LC/MS/MS. J Am Soc Mass Spectrom 24, 1338-1345, doi: 10.1007/s13361-013-0678-x (2013).
9. Chambers, A. G., Percy, A. J., Yang, J. & Borchers, C. H. Multiple Reaction Monitoring Enables Precise Quantification of 97 Proteins in Dried Blood Spots. Mol Cell Proteomics 14, 3094-3104, doi: 10.1074/mcp.O115.049957 (2015).
10. Chambers, A. G., Percy, A. J., Yang, J., Camenzind, A. G. & Borchers, C. H. Multiplexed quantitation of endogenous proteins in dried blood spots by multiple reaction monitoring-mass spectrometry. Mol Cell Proteomics 12, 781-791, doi: 10.1074/mcp.M112.022442 (2013).
11. Holguin, A. et al. Dried blood as an alternative to plasma or serum for Trypanosoma cruzi IgG detection in screening programs. Clin Vaccine Immunol 20, 1197-1202, doi: 10.1128/CVI.00221-13 (2013).
12. Ignjatovic, V., Pitt, J., Monagle, P. & Craig, J. M. The utility of dried blood spots for proteomic studies: looking forward to looking back. Proteomics Clin Appl 8, 896-900, doi: 10.1002/prca.201400042 (2014).
13. Ciccimaro, E. & Blair, I. A. Stable-isotope dilution LC-MS for quantitative biomarker analysis. Bioanalysis 2, 311-341, doi: 10.4155/ bio.09.185 (2010).
14. Cohen Freue, G. V. & Borchers, C. H. Multiple reaction monitoring (MRM): principles and application to coronary artery disease. Circulation. Cardiovascular genetics 5, 378, doi: 10.1161/CIRCGENETICS.111.959528 (2012).
15. Mohammed, Y. et al. PeptidePicker: a scientific workflow with web interface for selecting appropriate peptides for targeted proteomics experiments. J Proteomics 106, 151-161, doi: 10.1016/j.jprot.2014.04.018 (2014).
16. Mohammed, Y. et al. PeptideTracker: A knowledge base for collecting and storing information on protein concentrations in biological tissues. Proteomics, doi: 10.1002/pmic.201600210 (2016).
17. Kusebauch, U. et al. Human SRMAtlas: A Resource of Targeted Assays to Quantify the Complete Human Proteome. Cell 166, 766-778, doi: 10.1016/j.cell.2016.06.041 (2016).
18. Kusebauch, U. et al. Using PeptideAtlas, SRMAtlas, and PASSEL: Comprehensive Resources for Discovery and Targeted Proteomics. Current protocols in bioinformatics 46, 13 25 11-28, doi: 10.1002/0471250953.bi1325s46 (2014).
19. Bettegowda, C. et al. Detection of circulating tumor DNA in early- and late-stage human malignancies. Science translational medicine 6, 224ra224, doi: 10.1126/scitranslmed.3007094 (2014).
20. Karachaliou, N., Mayo-de-Las-Casas, C., Molina-Vila, M. A. & Rosell, R. Real-time liquid biopsies become a reality in cancer treatment. Annals of translational medicine 3, 36, doi: 10.3978/j.issn.2305-5839.2015.01.16 (2015).
21. Parker, S. P. & Cubitt, W. D. The use of the dried blood spot sample in epidemiological studies. Journal of clinical pathology 52, 633-639 (1999).
22. Bowen, C. L., Hemberger, M. D., Kehler, J. R. & Evans, C. A. Utility of dried blood spot sampling and storage for increased stability of photosensitive compounds. Bioanalysis 2, 1823-1828, doi: 10.4155/bio.10.142 (2010).
23. Mei, J. V., Alexander, J. R., Adam, B. W. & Hannon, W. H. Use of filter paper for the collection and analysis of human whole blood specimens. The Journal of nutrition 131, 1631S-1636S (2001).
24. Guthrie, R. & Susi, A. A Simple Phenylalanine Method for Detecting Phenylketonuria in Large Populations of Newborn Infants. Pediatrics 32, 338-343 (1963).
25. Demirev, P. A. Dried blood spots: analysis and applications. Anal Chem 85, 779-789, doi: 10.1021/ac303205m (2013).
26. Li, W. & Tse, F. L. Dried blood spot sampling in combination with LC-MS/MS for quantitative analysis of small molecules. Biomedical chromatography: BMC 24, 49-65, doi: 10.1002/bmc.1367 (2010).
27. Edwards, R. L., Griffiths, P., Bunch, J. & Cooper, H. J. Top-down proteomics and direct surface sampling of neonatal dried blood spots: diagnosis of unknown hemoglobin variants. J Am Soc Mass Spectrom 23, 1921-1930, doi: 10.1007/s13361-012-0477-9 (2012).
28. Martin, N. J., Bunch, J. & Cooper, H. J. Dried blood spot proteomics: surface extraction of endogenous proteins coupled with automated sample preparation and mass spectrometry analysis. J Am Soc Mass Spectrom 24, 1242-1249, doi: 10.1007/s13361-013- 0658-1 (2013).
29. Abbatiello, S. E., Mani, D. R., Keshishian, H. & Carr, S. A. Automated detection of inaccurate and imprecise transitions in peptide quantification by multiple reaction monitoring mass spectrometry. Clin Chem 56, 291-305, doi: 10.1373/clinchem.2009.138420 (2010).
30. Chace, D. H., Barr J. R., Duncan, M. W., Matern, D., Morris, M. R., Palmer-Toy, D. E., Rockwood, A. L., Siuzdak, G., Urbani, A., Yergev, A. L. & Chan, Y. M. Mass spectrometry in the clinical laboratory: general principles and guidance; approved guideline. Clinical and Laboratory Standards Institute 27 (2006).
31. Kuzyk, M. A. et al. Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma. Mol Cell Proteomics 8, 1860-1877, doi: 10.1074/mcp.M800540-MCP200 (2009).
32. Agger, S. A., Marney, L. C. & Hoofnagle, A. N. Simultaneous quantification of apolipoprotein A-I and apolipoprotein B by liquidchromatography- multiple- reaction-monitoring mass spectrometry. Clin Chem 56, 1804-1813, doi: 10.1373/clinchem.2010.152264 (2010).
33. Kuzyk, M. A., Parker, C. E., Domanski, D. & Borchers, C. H. Development of MRM-based assays for the absolute quantitation of plasma proteins. Methods Mol Biol 1023, 53-82, doi: 10.1007/978-1-4614-7209-4-4 (2013).
34. Haudek, V. J. et al. Proteome maps of the main human peripheral blood constituents. J Proteome Res 8, 3834-3843, doi: 10.1021/ pr801085g (2009).
35. MacLean, B. et al. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 26, 966-968, doi: 10.1093/bioinformatics/btq054 (2010).
36. R Core Team.: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria., https://www.R-project.org/ (2015).
37. Dudoit, S., Yang, Y. H., Callow, M. J. & Speed, T. P. Statistical methods for identifying differentially expressed genes in replicated cDNA microarray experiments. Stat Sinica 12, 111-139 (2002).
38. Benjamini, Y. & Hochberg, Y. Controlling the False Discovery Rate - a Practical and Powerful Approach to Multiple Testing. J Roy Stat Soc B Met 57, 289-300 (1995).
39. Schiff, M. H., Jaffe, J. S. & Freundlich, B. Head-to-head, randomised, crossover study of oral versus subcutaneous methotrexate in patients with rheumatoid arthritis: drug-exposure limitations of oral methotrexate at doses> /= 15 mg may be overcome with subcutaneous administration. Ann Rheum Dis 73, 1549-1551, doi: 10.1136/annrheumdis-2014-205228 (2014).
40. Bland, J. M. & Altman, D. G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1, 307-310 (1986).
41. Fox, J. & Weisberg, S. An R Companion to Applied Regression. Second edn, (Sage, 2011).